POS1175 ANTI-IL5 THERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: DOSAGE, EFFICACY AND OUTCOME IN A LARGE COHORT OF PATIENTS IN REAL LIFE (REVAS STUDY)-MedSci.cn - 梅斯（MedSci）

POS1175 ANTI-IL5 THERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: DOSAGE, EFFICACY AND OUTCOME IN A LARGE COHORT OF PATIENTS IN REAL LIFE (REVAS STUDY)

Solans-Laqué, R; Mozo, AN; Callejas-Rubio, JL; Fonseca, E; Sopeña, B; Solanich, X; Mestre, J; Rios, JJ; Ausin, C

ANNALS OF THE RHEUMATIC DISEASES, 2023; 82 (): 920

科室
- - 订阅+
  - 更多科室
工具
服务